Cost-Effectiveness Analysis of Using Everolimus or Axitinib in Patients with Metastatic Renal Cell Carcinoma WHO Have Failed to Use of Pazopanib or Sunitinib in First-Line Treatment
作者
ME Romero Prada,LM Huerfano,NC Roa Cardenas
出处
期刊:Value in Health [Elsevier BV] 日期:2016-10-31卷期号:19 (7): A735-A735被引量:1